Palatin Technologies
PTN
$1.73
Share price
-1.14%
Change (1 day)
-32.42%
Change (1 year)
Categories
Market capitalization of Palatin Technologies (PTN)
Market cap: $27.91 Million
As of April 2024 Palatin Technologies has a market cap of $27.91 Million. This makes Palatin Technologies the world's 7898th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Palatin Technologies from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $27.91 M | -48.94% |
| 2023 | $54.67 M | 106.27% |
| 2022 | $26.5 M | -77.6% |
| 2021 | $0.11 B | -23.87% |
| 2020 | $0.15 B | -13.28% |
| 2019 | $0.17 B | 24.62% |
| 2018 | $0.14 B | -12% |
| 2017 | $0.16 B | 142.55% |
| 2016 | $67.39 M | 49.19% |
| 2015 | $45.17 M | 48.96% |
| 2014 | $30.32 M | 5.41% |
| 2013 | $28.76 M | 23.12% |
| 2012 | $23.36 M | 66.58% |
| 2011 | $14.02 M | -12.35% |
| 2010 | $16 M | -54.99% |
| 2009 | $35.55 M | 356.31% |
| 2008 | $7.79 M | -54.28% |
| 2007 | $17.04 M | -88.26% |
| 2006 | $0.14 B | -24.6% |
| 2005 | $0.19 B | 34.01% |
| 2004 | $0.14 B | 26.58% |
| 2003 | $0.11 B | 102.25% |
| 2002 | $56.13 M | -17.02% |
| 2001 | $67.64 M |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Palatin Technologies was reported to be:
$27.91 Million
$27.91 Million
$27.83 Million
$27.91 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $357.92 B | 1,282,033.99% | 🇺🇸 USA |
 AstraZeneca AZN | $220.75 B | 790,660.86% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $13.97 B | 49,969.65% | 🇺🇸 USA |
 MediciNova MNOV | $66.45 M | 138.06% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.25 B | 4,403.02% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | 10,566.53% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $1.37 B | 4,817.34% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $0.11 B | 328.26% | 🇺🇸 USA |
 Ardelyx ARDX | $1.49 B | 5,259.49% | 🇺🇸 USA |